| 000 | 00000nam##2200000za#4500 |
| 001 | 9.615261 |
|---|
| 003 | CaOODSP |
|---|
| 005 | 20210615101040 |
|---|
| 007 | ta |
|---|
| 008 | 150406|2000||||xxc||||| f|0| 0 eng|d |
|---|
| 020 | |a0-662-29194-8 |
|---|
| 040 | |aCaOODSP|beng |
|---|
| 043 | |an-cn--- |
|---|
| 086 | 1 |aH42-2/67-18-2000E |
|---|
| 110 | 1 |aCanada. |bHealth Products and Food Branch. |
|---|
| 245 | 10|aViral safety evaluation of biotechnology products derived from cell lines of human or animal origin / |cIssued by the International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use. |
|---|
| 260 | |aOttawa - Ontario : |bHealth Canada. |c2000. |
|---|
| 300 | |aiii, 32p. ; |c28 cm. |
|---|
| 490 | 1 |aGuidance for industry|vICH Topic Q5A |
|---|
| 563 | |aLoose-leaf |
|---|
| 590 | |a01-08|b2001-02-23 |
|---|
| 690 | 07|aBiotechnology|2gcpds |
|---|
| 690 | 07|aContamination|2gcpds |
|---|
| 690 | 07|aBiochemical products|2gcpds |
|---|
| 776 | 0#|tViral safety evaluation of biotechnology products derived from cell lines of human or animal origin |w(CaOODSP)9.573957 |
|---|
| 830 | #0|aGuidance for industry ;|vICH Topic Q5A|w(CaOODSP)9.514730 |
|---|